PharmaTelevision - Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss:

• Orion's origins and growth in Europe

• Orion's organic growth as opposed to acquisitions

• Why a licensor should consider Orion

• How recent acquisitions by big pharma affect Orion

• Licensing arrangements and global rights in a mid-size company

• Orion's agenda for the next 5 years

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Orion Corporation 's origins and growth in Europe.

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here in Barcelona at BioEurope. On this show I have Jukka Muhonen, who is the Business Development Director at Orion Corporation which is headquartered in Finland, welcome to the show.

Jukka Muhonen:

Thank you, good morning.

Fintan Walton:

Good morning to you. Orion or Orion Corporation is a mid-sized European Company focused obviously in pharmaceuticals tell us little bit about the origins of that company and how it's grown in recent times particularly in its presence here in Europe?

Jukka Muhonen:

Yes, some years back we celebrated our 90th anniversary, so we've been founded in 1917 and as you said we've grown out of Finland, we are headquartered there and that's our home market as we like to see. We've been the leading company there for a number of years and still we are in the lead in Finland in terms of sales we hold a market share of 9.5% if I remember it's certainly right and in terms of volume the stake is even, even larger around one third of the packages in pharmaceuticals sold in Finland are Orion Corporation packages. So that's our home turf and from there we've gradually grown into Scandinavia and Central Europe and for some years already we've been active in Eastern Europe and that market is a growth area for us and it has been. And then recently, as recently as last year we opened up subsidiaries in Southern Europe also. So we like to see ourselves as a regional pharmaceutical and diagnostics company who is European and who is headquartered in Finland.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Jukka Muhonen

Life Science Manager

Mr. Jukka Muhonen has been responsible for Orion Corporation's strategic partnerships since the beginning of 2007.A lawyer by training, Jukka Muhonen joined Orion Corporation and the pharmaceutical industry in 1998. His previous employment history included stints with Telecom Finland (now Sonera) and a corporate law firm.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

Orion Corporation

Orion Corporation , founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.